Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women.
about
Hormone replacement for osteoporosis in women with primary biliary cirrhosisHormone replacement for osteoporosis in women with primary biliary cirrhosisDiscordance in diagnosis of osteoporosis using spine and hip bone densitometryThe treatment of climacteric symptomsAn overview on the treatment of postmenopausal osteoporosisLipid metabolism disorders and bone dysfunction--interrelated and mutually regulated (review)The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosisCathepsin K inhibitors for osteoporosis and potential off-target effectsAdvances in hormone replacement therapy: making the menopause manageableLong-term supplementation with young coconut juice does not prevent bone loss but rather alleviates body weight gain in ovariectomized ratsSafety of drugs used in the treatment of osteoporosis.Prevention and treatment of postmenopausal osteoporosis.Risks and benefits of hormone replacement therapy: the evidence speaks.Testosterone increases bone mineral density in female-to-male transsexuals: a case series of 15 subjectsIncorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan.The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men.Similarities in acquired factors related to postmenopausal osteoporosis and sarcopenia.Soy isoflavone intake and bone mineral density in breast cancer survivors.HDL cholesterol and bone mineral density: is there a genetic link?From in vivo gene targeting of oestrogen receptors to optimization of their modulation in menopause.Ovarian dysfunction, stress, and disease: a primate continuum.Hormone replacement therapy and the prevention of postmenopausal osteoporosis.Management of age-related osteoporosis and prevention of associated fractures.Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based AnalysisThe effect of female sex hormone supplementation on tendon in pre and postmenopausal women: A systematic review.Does menopausal hormone therapy (MHT), exercise or a combination of both, improve pain and function in post-menopausal women with greater trochanteric pain syndrome (GTPS)? A randomised controlled trial.Response to an adequate dietary intake of vitamin D3 modulates the effect of estrogen therapy on bone densityTreatment of menopausal symptoms post-Women's Health Initiative: refinement of existing treatments and development of new therapies.Hormone therapy: maximizing the benefits.Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study.Estrogen therapy for postmenopausal osteoporosis.Osteoporosis and periodontal disease.Bioidentical hormone therapy: Nova Scotia pharmacists' knowledge and beliefsThe tissue selective estrogen complex: a promising new menopausal therapyHormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60-64 Years: A British Birth Cohort.Osteoprotective effect of hormone therapy on bone microarchitecture before impaired bone mineral density in ovariectomized rats.Bone mineral density in African–American women with symptomatic uterine leiomyoma.Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines.Individualizing osteoporosis therapy.
P2860
Q24234575-5D2CFE7E-AB76-464B-9CBC-211F2CFD62B6Q24234784-92720F29-75A1-4CEE-8C1A-F5CAB4EFE463Q24803771-E037C09C-9540-4013-8BCD-CEF70A44C758Q26992273-9625A5F1-2935-4AA1-BF09-C97B8A9350F4Q27013070-521C4427-ED8A-4C9E-BA6D-40F2DEABD15AQ28083206-DA2EA5C0-41E6-4BA2-AA7F-04C0A88B4B36Q28263058-D790E6FF-A313-42A8-B0BD-EE01C7CA87E0Q29042565-7D6C8F31-8FFE-4C93-9F94-C7BE73B9BC38Q33387664-7D53AB9F-A573-4D73-AE17-FE93B80A2F63Q33685435-03CE0CCB-4138-40F2-85EF-BDB7F777934FQ33949479-ED0696EB-357B-4FF6-BC87-B2A39FB8BF1EQ34296614-D741517A-1944-4245-9B95-134C56159D49Q34899934-DB8B36CC-C294-4CF4-920C-193A3E341B97Q34995426-43695733-3357-4F60-9CBA-ECB8583E317EQ35092609-1C1E41F5-299E-47AE-BFE1-E1F5999A7D71Q35110262-CE4D6966-CA78-4B3C-A28B-009F710BC90FQ35195120-F0EECBBF-B0ED-413A-BB77-7BC22419629AQ35202433-5EE1037B-ADCF-49ED-8505-FAD3D47C40C7Q35608491-93A8D488-5F25-41E2-8902-D8AFA7880080Q35657905-3C7FB0EF-0193-4AFF-AB9E-11ACFC90C2F1Q35757541-F30684F5-B5F8-498A-A9D2-37EE9BCD37FBQ35903603-E01BC8C8-DCE1-409F-9523-F478A7C50E66Q35919125-89D45640-3895-46E2-9DF8-E47239B6E783Q36045845-99FD2463-DF63-4D0A-9B4C-4C90BC8F5BC5Q36047352-279DFC27-77C4-4343-A846-1061DF522CB8Q36054925-9422CFDD-EEBC-4785-88DC-1B9BD603BBB9Q36138452-C137E4EC-8C73-4F4E-8514-793C042F68E8Q36219667-4EF23CC6-8D23-4F3B-BBAF-954D5C248EE7Q36533644-F19977B7-CDEE-4288-849C-34477C355A10Q36535984-475BC07F-05FC-40C1-8EBE-31CD824CBA01Q36658946-BBA93513-7DEF-498B-86E7-86FB00468F66Q36809161-76BD082F-6488-4E43-839A-44084380BE46Q37190890-F20A272B-4399-4E77-9D42-2B84144E08F0Q37277298-56819CA3-FD64-45B7-82E1-808B4996DD33Q37292711-6E2048D6-0A8A-47BA-ABF5-EAA9864368CAQ37314283-E5B256FD-1B78-4301-AE7F-0B9F4B323BBCQ37437256-55F28570-6DF5-4A37-BBE1-C02715BA8C19Q37795801-4961D380-323A-4E25-8253-85CA6BCEEF52Q37911560-058908EB-B1AA-4BEF-9DED-05D15BA53BF1Q37973239-0419E657-4155-4D90-A766-E9B3B38D7FA8
P2860
Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Meta-analyses of therapies for ...... rosis in postmenopausal women.
@ast
Meta-analyses of therapies for ...... rosis in postmenopausal women.
@en
Meta-analyses of therapies for ...... rosis in postmenopausal women.
@nl
type
label
Meta-analyses of therapies for ...... rosis in postmenopausal women.
@ast
Meta-analyses of therapies for ...... rosis in postmenopausal women.
@en
Meta-analyses of therapies for ...... rosis in postmenopausal women.
@nl
prefLabel
Meta-analyses of therapies for ...... rosis in postmenopausal women.
@ast
Meta-analyses of therapies for ...... rosis in postmenopausal women.
@en
Meta-analyses of therapies for ...... rosis in postmenopausal women.
@nl
P2093
P50
P356
P1433
P1476
Meta-analyses of therapies for ...... rosis in postmenopausal women.
@en
P2093
Ann Cranney
Beverley Shea
Diane O'Connell
George Wells
Joan Peterson
Nicole Zytaruk
Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group
Vivian Robinson
P304
P356
10.1210/ER.2001-5002
P577
2002-08-01T00:00:00Z